Pediatric Cephalexin Dosing for Staphylococcal Infections
For pediatric staphylococcal skin and soft tissue infections, administer cephalexin at 25-50 mg/kg/day divided into doses given every 6-12 hours for 5-7 days, with the specific frequency depending on infection severity and local MRSA prevalence.
Dosing Recommendations
Standard Dosing from FDA Label
The FDA-approved dosing for pediatric patients is 25-50 mg/kg/day in divided doses 1. For skin and skin structure infections specifically, this total daily dose may be divided and administered every 12 hours in children over 1 year of age 1.
Practical Dosing by Frequency
For twice-daily (BID) dosing:
- Use 22-45 mg/kg/day divided BID for MSSA with MIC 1-2 mg/L
- This achieves adequate pharmacodynamic targets in >90% of children 2
- Improves compliance compared to QID dosing 3, 4
For three times daily (TID) dosing:
- Use 15-25 mg/kg/day divided TID for standard MSSA infections 2
- Validated in osteoarticular infections with 100% clinical cure rates 5
For four times daily (QID) dosing:
- Reserve for severe infections or less susceptible organisms 1
- May double the standard dose in severe infections 1
Critical Caveat: MRSA Prevalence
The most important clinical pitfall is that cephalexin has NO activity against MRSA, which now represents 87.8% of community-acquired S. aureus skin infections 6. However, for simple abscesses after incision and drainage, antibiotics may be unnecessary regardless—placebo achieved 90.5% cure versus 84.1% with cephalexin 6.
When to Use Cephalexin:
- Only if local susceptibility data confirms MSSA
- After culture results return showing methicillin-sensitive strains
- In areas with low MRSA prevalence (<10-15%)
When NOT to Use Cephalexin:
- Empiric therapy in areas with high MRSA prevalence
- Necrotizing infections (requires IV therapy per IDSA guidelines 7)
- Treatment failure after initial drainage
Treatment Duration
5-7 days of therapy is typically adequate for uncomplicated skin and soft tissue infections 8. Response should be evident within the first few days of treatment 8.
For β-hemolytic streptococcal infections (if co-infection suspected), extend treatment to at least 10 days 1.
Dosing Algorithm
- Confirm MSSA susceptibility (or high local prevalence of MSSA)
- Calculate total daily dose: 25-50 mg/kg/day based on severity
- Choose frequency:
- BID dosing: Best for compliance, adequate for most infections
- TID dosing: Alternative if concerned about coverage
- QID dosing: Only for severe infections
- Duration: 5-7 days for skin/soft tissue; 10 days if streptococcal co-infection
- Reassess at 48-72 hours: If no improvement, consider MRSA coverage
Severe Infections Requiring Different Approach
For necrotizing fasciitis or deep tissue staphylococcal infections, the IDSA guidelines recommend IV therapy 7:
- Nafcillin or oxacillin: 50 mg/kg/dose every 6 hours IV
- Cefazolin: 33 mg/kg/dose every 8 hours IV
- Vancomycin (if MRSA): 15 mg/kg/dose every 6 hours IV
Oral cephalexin is inappropriate for these life-threatening infections.